Maraviroc shows potential for HIV PrEP in women

DURBAN, SOUTH AFRICA – Maraviroc-containing regimens for daily oral pre-exposure prophylaxis in women at risk for HIV infection showed good safety and tolerability in a phase 2 study, the first...

Source: Ob.Gyn. News - August 29, 2016 Category: OBGYN Source Type: research